HebeCell was founded in 2016 by a group of scientists who wanted to push research in regenerative medicine and immuno-oncology farther than ever before. Our team of researchers includes multiple world-leading experts in stem cell biology, as well as experienced entrepreneurs and business developers. We operate a fully-equipped state-of-the-art laboratory in Natick, MA, one of the world’s largest biotech hubs.
Since 2016, we have grown HebeCell into a leading innovator in our field. Most importantly, we have developed and patented a method of producing allogeneic natural killer (NK) cells indefinitely from induced pluripotent stem cells (iPS cells) by suspending them in a liquid solution within specially engineered bioreactors. No other company or lab has this technology or these capabilities. We currently focus on developing universal, cost-effective & off-the-shelf NK cell therapeutics from iPS cells, readily available to ALL patients worldwide, for the treatment of cancer, infectious and autoimmune diseases.
